€ million |
Jan – Sep |
Jan – Sep |
||
|
||||
Income |
2,967 |
2,459 |
||
Depreciation, amortisation, impairment losses, write backs |
1,754 |
1,612 |
||
Changes in provisions |
–1,058 |
–123 |
||
Deferred taxes / non-cash income and expenses / income from disposal of non-current assets and marketable securities |
256 |
1,577 |
||
Changes in working capital |
207 |
–1,176 |
||
Cash flows from operating activities of continuing operations |
4,126 |
4,349 |
||
Cash flows from operating activities of discontinued operations |
11 |
288 |
||
Cash flows from operating activities |
4,137 |
4,637 |
||
Capital expenditure on non-current assets / acquisitions |
–12,223 |
–3,339 |
||
Proceeds from disposal of assets / divestitures |
1,098 |
1,091 |
||
Changes in marketable securities and cash investments |
1,921 |
3,909 |
||
Cash flows from investing activities of continuing operations1 |
–9,204 |
1,661 |
||
Cash flows from investing activities of discontinued operations |
–78 |
–487 |
||
Cash flows from investing activities |
–9,282 |
1,174 |
||
Cash flows from financing activities of continuing operations |
7,144 |
–5,387 |
||
Cash flows from financing activities of discontinued operations |
65 |
195 |
||
Cash flows from financing activities |
7,209 |
–5,192 |
||
Net cash change in cash and cash equivalents |
2,064 |
619 |
||
Effects of changes in foreign exchange rates and other changes in value on cash and cash equivalents |
12 |
4 |
||
Net cash change in cash and cash equivalents from discontinued operations |
2 |
4 |
||
Net change in cash and cash equivalents |
2,078 |
627 |
||
Cash and cash equivalents at beginning of the reporting period |
1,249 |
1,922 |
||
Cash and cash equivalents at end of the reporting period |
3,327 |
2,549 |
||